BCL2 and breast cancer: Third, several therapeutic strategies targeting anti-apoptotic BCL-2 family members are currently under investigation; therefore, understanding which BCL-2 proteins each phenotype is expressing may provide insight into additional treatment strategies for breast cancer [22, 92–94].